IBM’s Watson Has Big Plans in Health Care

With many major medical centers investing a lot in IBM and Watson, it seems it will eventually have an impact. How soon is a different question.

Feb 11, 2014 at 6:30PM

IBM (NYSE:IBM) has big plans for its Watson artificial-intelligence computer. Money-making plans, that is, especially in the fields of finance and health care.

Motley Fool analysts Rex Moore and Max Macaluso chatted with Pristine co-founder Kyle Samani at the recent mHealth Summit near Washington, D.C. Samani believes IBM's Watson and similar approaches to "predictive analytics" will eventually make major contributions to the health care field, although they're not currently generating any real-world value.

A full transcript follows the video.

The Motley Fool's top stock in 2014
There’s a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Max Macaluso: Do you have any thoughts on the IBM Watson project?

Kyle Samani: I do have some thoughts on it. I actually know quite a bit about it; I've done some good research, and I know a lot of people who work on the teams and I've spoken with them. I think the vision is very compelling and very ambitious. I love it.

Today, it's effectively doing nothing, in the real world. The real world value being generated is nothing. There's a lot of major medical centers investing a lot in Watson -- or I should say with IBM -- because they believe in that vision, and I applaud them for doing so.

I'm optimistic that, in time, it will happen. Telling you if that's going to be 3 years or 8 years or 15 years? I have no ability to assess that today. No one does, including anyone on the Watson team. The technical side, I suspect, will solve itself. The harder problem is probably the regulatory side, and I'm not sure what to make of how that will play itself out.

I fully expect Watson -- or Watson-like technologies; let's just call them "predictive analytics" -- will become a major part of the future of health care delivery, but it's still a long ways off. There's a lot that needs to be done first.

Max Macaluso, Ph.D. has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. Rex Moore has no position in any stocks mentioned. The Motley Fool owns shares of International Business Machines. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information